Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension

Journal of the American Society of Hypertension

Volumn 6, Issue 2, 2012, Pages 142-151

  Flack, John M ^a   Yadao, Anthony M ^b   Purkayastha, Das ^b   Samuel, Rita ^b   White, William B ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Aliskiren; ambulatory blood pressure; combination therapy; stage 2 hypertension; valsartan

Indexed keywords

ALISKIREN PLUS VALSARTAN; VALSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE;

AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DRUG THERAPY, COMBINATION; FEMALE; FUMARATES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 84858699502     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2011.11.004     Document Type: Article

References (21)

1. T. Morgan, A. Anderson, D. Bertram, and R.J. MacInnis Effect of candesartan alone and in combination on blood pressure and microalbuminuria J Renin Angiotensin Aldosterone Syst 5 2004 64 71 (Pubitemid 39010812)
2. T.W.R. Doulton, F.J. He, and M.A. Graham Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension Hypertension 45 2005 880 886 (Pubitemid 40628932)
3. S. Yusuf, S. Teo, K.K. Pogue, J. Dyal, L. Copland, and I. Schumacher Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559 (Pubitemid 351522739)
4. L.M. Ruilope, J.C. Aldigier, C. Ponticelli, P. Oddou-Stock, F. Botteri, and J.F. Mann Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease J Hypertens 18 2000 89 95 (Pubitemid 30093713)
5. R. Kunz, C. Friedrich, M. Wolbers, and J.F. Mann Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease Ann Intern Med 148 2008 30 48 (Pubitemid 351688350)
6. M. MacKinnon, S. Shurraw, A. Akbari, G.A. Knoll, J. Jaffey, and H.D. Clark Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data Am J Kidney Dis 48 2006 8 20
7. H.H. Parving, F. Persson, J.B. Lewis, E.J. Lewis, and N.K. Hollenberg AVOID Study Investigators. Aliskiren combined with losartan in type 2 diabetes and nephropathy N Engl J Med 358 2008 2433 2446 (Pubitemid 351793017)
8. F. Persson, P. Rossing, H. Reinhard, T. Juhl, C.D. Stehouwer, and C. Schalkwijk Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria Diabetes Care 32 2009 1873 1879
9. K. Andersen, M.H. Weinberger, B. Egan, C.M. Constance, M.A. Ali, and J. Jin Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial J Hypertens 26 2008 589 599
10. P. Verdecchia, F. Angeli, G. Mazzotta, P. Martire, M. Garofoli, and G. Gentile Aliskiren versus ramipril in hypertension Ther Adv Cardiovasc Dis 4 2010 193 200
11. W.B. White, R. Bresalier, A.P. Kaplan, B.F. Palmer, R.H. Riddell, and A. Lesogor Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension J Clin Hypertens (Greenwich) 12 2010 765 775
12. W.B. White, R. Bresalier, A.P. Kaplan, B.F. Palmer, R.H. Riddell, and A. Lesogor Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients J Clin Hypertens (Greenwich) 13 2011 506 516
13. S. Oparil, S.A. Yarows, S. Patel, H. Fang, J. Zhang, and A. Satlin Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial Lancet 370 2007 221 229 (Pubitemid 47069535)
14. G.L. Bakris, L.H. Lindholm, H.R. Black, H. Krum, S. Linas, and J.V. Linseman Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial Hypertension 56 2010 824 830
15. E. Dolan, A. Stanton, L. Thijs, K. Hinedi, N. Atkins, and S. McClory Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study Hypertension 46 2005 156 161 (Pubitemid 40946507)
16. E. Dolan, A.V. Stanton, S. Thom, M. Caulfield, N. Atkins, and G. McInnes ASCOT Investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients - an Anglo-Scandinavian cardiac outcomes trial substudy J Hypertens 27 2009 876 885
17. S.A. Yarows, S. Oparil, S. Patel, H. Fang, and J. Zhang Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study Adv Ther 25 2008 1288 1302
18. J.M. Flack, G.A. Mensah, and C.M. Ferrario Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage Curr Med Res Opin 16 2000 66 79 (Pubitemid 30426769)
19. P. Campbell, N. Ghuman, D. Wakefield, L. Wolfson, and W.B. White Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly J Hum Hypertens 24 2010 749 754
20. T.G. Pickering, W.B. White, T.D. Giles, H.R. Black, J.L. Izzo, and B.J. Materson When and how to use self (home) and ambulatory blood pressure monitoring J Am Soc Hypertens 4 2010 56 61
21. nd edition. p. 500